Brand Name :
Lumify, alphagan P,Qoliana
Synonyms :
brimonidine
Class :
Antiglaucoma
Dosage Forms & Strengths
Ophthalmic solution (Rx)
0.15%
0.1%
One drop in the affected eye every 8 hours
Administer one drop in each affected eye every 6-8 hours
Dosage Forms & Strengths
Ophthalmic solution (Rx)
0.15%
0.1%
<2 years: Contraindicated >2 years: 1 drop in the affected eye every 8 hours
<5 years: Safety and efficacy not established >5 years: Administer one drop in each affected eye every 6-8 hours
Refer adult dosing
It may enhance sedation when combined with oxycodone
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the toxic effect
may increase the toxic effect
may increase the toxic effect
may increase the toxic effect
may increase the toxic effect
may increase the bradycardiac effect
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
may have an increased Effect of a CNS depressant when combined with CNS depressants
may have an increased Effect of a CNS depressant when combined with CNS depressants
may have an increased Effect of a CNS depressant when combined with CNS depressants
brimonidine and triprolidine lead to increased sedative effects
brimonidine: they may increase the hypotensive effect when combined with blood viscosity-reducing agents
brimonidine: they may increase the hypotensive effect when combined with blood viscosity-reducing agents
may have an increased hypotensive effect when combined with antihypertensive agents
may increase the toxic effect
may increase the CNS depressant effect
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the hypotensive effect of Blood Pressure Lowering Agents
may increase the CNS depressant effect of CNS Depressants
Frequency not defined:
Conjunctival hyperemia
Eye pruritis
Photophobia
Fatigue
Dyspepsia
Eye discharge
Oral dryness
Allergic conjunctivitis
Rash
Headache
Dizziness
Blepharitis
Pregnancy consideration: B
Lactation: Excretion of the drug in human breast milk is unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient information leaflet
Generic Name: brimonidine
Pronounced: ( bri-moni-dine)
Why do we use brimonidine?
It is used to treat ocular hypertension and glaucoma
ADVERTISEMENT
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
